MX348733B - Composiciones de radiorastreador de peptido. - Google Patents
Composiciones de radiorastreador de peptido.Info
- Publication number
- MX348733B MX348733B MX2013001939A MX2013001939A MX348733B MX 348733 B MX348733 B MX 348733B MX 2013001939 A MX2013001939 A MX 2013001939A MX 2013001939 A MX2013001939 A MX 2013001939A MX 348733 B MX348733 B MX 348733B
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- trainer
- peptide
- radio
- imaging
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012216 imaging agent Substances 0.000 abstract 1
- 238000003384 imaging method Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000011503 in vivo imaging Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002600 positron emission tomography Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nuclear Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1013808.9A GB201013808D0 (en) | 2010-08-18 | 2010-08-18 | Peptide radiotracer compositions |
| PCT/EP2011/063890 WO2012022676A1 (en) | 2010-08-18 | 2011-08-11 | Peptide radiotracer compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013001939A MX2013001939A (es) | 2013-03-18 |
| MX348733B true MX348733B (es) | 2017-06-27 |
Family
ID=42938098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013001939A MX348733B (es) | 2010-08-18 | 2011-08-11 | Composiciones de radiorastreador de peptido. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9533059B2 (enExample) |
| EP (1) | EP2605802B1 (enExample) |
| JP (1) | JP6014592B2 (enExample) |
| KR (1) | KR101853993B1 (enExample) |
| CN (1) | CN103153350B (enExample) |
| AU (1) | AU2011290856B2 (enExample) |
| BR (1) | BR112013003469A2 (enExample) |
| CA (1) | CA2807491C (enExample) |
| CL (1) | CL2013000483A1 (enExample) |
| ES (1) | ES2626410T3 (enExample) |
| GB (1) | GB201013808D0 (enExample) |
| IL (1) | IL224463A (enExample) |
| MX (1) | MX348733B (enExample) |
| MY (1) | MY163136A (enExample) |
| NZ (1) | NZ606466A (enExample) |
| PH (1) | PH12013500270A1 (enExample) |
| RU (1) | RU2594167C2 (enExample) |
| SG (1) | SG187878A1 (enExample) |
| WO (1) | WO2012022676A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201103696D0 (en) | 2011-03-04 | 2011-04-20 | Ge Healthcare Ltd | Technetium labelled peptides |
| GB201121914D0 (en) | 2011-12-20 | 2012-02-01 | Ge Healthcare Ltd | Method for patient selection |
| GB201209082D0 (en) * | 2012-05-24 | 2012-07-04 | Ge Healthcare Ltd | Purification method |
| GB201221266D0 (en) * | 2012-11-27 | 2013-01-09 | Ge Healthcare Ltd | Aldehyde compositions |
| GB201314936D0 (en) | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
| GB201322451D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Purification method and compositions |
| GB201322456D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
| WO2018022603A1 (en) * | 2016-07-25 | 2018-02-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of making 18f-labeled precursors and peptides, labeled c-met binding peptides, and methods of use thereof |
| GB201804835D0 (en) * | 2018-03-26 | 2018-05-09 | Ge Healthcare As | Formulation and method of preparation |
| GB2598676A (en) | 2019-06-14 | 2022-03-09 | Edinburgh Molecular Imaging Ltd | Compounds and methods of use |
| GB201915206D0 (en) * | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
| SE2050387A1 (en) * | 2020-04-06 | 2021-10-07 | Pvac Medical Tech Ltd | Labelled substance and methods of detection of inflammation and infection using said substance |
| TW202509086A (zh) * | 2021-03-22 | 2025-03-01 | 日商肽夢想股份有限公司 | c－Met蛋白質結合肽複合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5961955A (en) * | 1997-06-03 | 1999-10-05 | Coulter Pharmaceutical, Inc. | Radioprotectant for peptides labeled with radioisotope |
| AU2002357388A1 (en) | 2001-12-27 | 2003-07-24 | The United States Of America, As Represented By The Department Of Veterans Affairs | Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| JP5466350B2 (ja) | 2003-03-03 | 2014-04-09 | ダイアックス、コープ | ＨＧＦレセプター（ｃＭｅｔ）を特異的に結合するペプチドおよびその使用 |
| GB0305704D0 (en) * | 2003-03-13 | 2003-04-16 | Amersham Plc | Radiofluorination methods |
| GB0420344D0 (en) * | 2004-09-14 | 2004-10-13 | Amersham Plc | Diagnostic compounds |
| JP2009542689A (ja) * | 2006-07-07 | 2009-12-03 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 選択的カスパーゼ阻害剤 |
| GB0615211D0 (en) | 2006-07-31 | 2006-09-06 | Ge Healthcare Uk Ltd | Asymmetric flouro-substituted polymethine dyes |
| MX2009002492A (es) | 2006-09-08 | 2009-08-28 | Bayer Schering Pharma Ag | Agentes que comprenden compuestos marcados con 18f y metodos relacionados. |
| WO2008072976A2 (en) | 2006-12-13 | 2008-06-19 | Ge Healthcare As | Synthesis of a radiofluorinated peptide using microwave activation technology |
| WO2008083191A2 (en) * | 2006-12-28 | 2008-07-10 | Ge Healthcare As | Radiofluorination methods |
| JP2010520229A (ja) | 2007-03-01 | 2010-06-10 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | 放射性弗素化方法 |
| AU2008249821B2 (en) | 2007-05-16 | 2013-08-22 | Ge Healthcare As | Labelled HGF binding peptides for imaging |
| GB0718967D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Peptide imaging agents |
| GB0718957D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Optical imaging agents |
| GB0716897D0 (en) | 2007-08-30 | 2007-10-10 | Univ Muenchen Tech | Cancer imaging and treatment |
| GB0803477D0 (en) * | 2008-02-26 | 2008-04-02 | Ge Healthcare As | Therapy selection method |
-
2010
- 2010-08-18 GB GBGB1013808.9A patent/GB201013808D0/en not_active Ceased
-
2011
- 2011-08-11 KR KR1020137006689A patent/KR101853993B1/ko active Active
- 2011-08-11 NZ NZ606466A patent/NZ606466A/en unknown
- 2011-08-11 US US13/816,589 patent/US9533059B2/en active Active
- 2011-08-11 CA CA2807491A patent/CA2807491C/en active Active
- 2011-08-11 SG SG2013011770A patent/SG187878A1/en unknown
- 2011-08-11 MY MYPI2013700257A patent/MY163136A/en unknown
- 2011-08-11 AU AU2011290856A patent/AU2011290856B2/en active Active
- 2011-08-11 WO PCT/EP2011/063890 patent/WO2012022676A1/en not_active Ceased
- 2011-08-11 EP EP11744007.3A patent/EP2605802B1/en active Active
- 2011-08-11 ES ES11744007.3T patent/ES2626410T3/es active Active
- 2011-08-11 JP JP2013524419A patent/JP6014592B2/ja active Active
- 2011-08-11 MX MX2013001939A patent/MX348733B/es active IP Right Grant
- 2011-08-11 CN CN201180050137.2A patent/CN103153350B/zh active Active
- 2011-08-11 PH PH1/2013/500270A patent/PH12013500270A1/en unknown
- 2011-08-11 BR BR112013003469A patent/BR112013003469A2/pt active Search and Examination
- 2011-08-11 RU RU2013105491/04A patent/RU2594167C2/ru active
-
2013
- 2013-01-29 IL IL224463A patent/IL224463A/en active IP Right Grant
- 2013-02-18 CL CL2013000483A patent/CL2013000483A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB201013808D0 (en) | 2010-09-29 |
| EP2605802B1 (en) | 2017-04-26 |
| CL2013000483A1 (es) | 2014-03-07 |
| KR101853993B1 (ko) | 2018-05-02 |
| RU2013105491A (ru) | 2014-09-27 |
| KR20130135242A (ko) | 2013-12-10 |
| JP6014592B2 (ja) | 2016-10-25 |
| CA2807491C (en) | 2019-06-04 |
| MY163136A (en) | 2017-08-15 |
| AU2011290856A1 (en) | 2013-03-14 |
| EP2605802A1 (en) | 2013-06-26 |
| CN103153350A (zh) | 2013-06-12 |
| BR112013003469A2 (pt) | 2016-06-21 |
| SG187878A1 (en) | 2013-03-28 |
| RU2594167C2 (ru) | 2016-08-10 |
| CN103153350B (zh) | 2016-06-29 |
| JP2013540702A (ja) | 2013-11-07 |
| WO2012022676A1 (en) | 2012-02-23 |
| MX2013001939A (es) | 2013-03-18 |
| IL224463A (en) | 2016-05-31 |
| ES2626410T3 (es) | 2017-07-25 |
| NZ606466A (en) | 2014-11-28 |
| AU2011290856B2 (en) | 2014-12-04 |
| CA2807491A1 (en) | 2012-02-23 |
| PH12013500270A1 (en) | 2013-04-01 |
| US9533059B2 (en) | 2017-01-03 |
| US20130149241A1 (en) | 2013-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX348733B (es) | Composiciones de radiorastreador de peptido. | |
| UY32037A (es) | Daa-piridina | |
| CL2013000100A1 (es) | Composicion que comprende un agente de contraste para rayos x yodado y un portador o excipiente farmaceuticamente aceptable, donde la concentracion de yodo es de 10-170 mgl/ml; un metodo de examen con rayos x que comprende el uso de la composicion. | |
| MX2017003886A (es) | Conjugado radiofarmaceutico de un metabolito y un agente epr para tratar celulas tumorales. | |
| PE20211760A1 (es) | Inhibidores marcados de antigeno prostatico especifico de membrana (psma) que comprenden grupos carboxilicos y una region de enlazador modificada, agentes formadores de imagenes y agentes farmaceuticos que los comprenden | |
| MY150757A (en) | Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins | |
| MX2013012793A (es) | Aminoacidos radiomarcados para imagen de diagnostico. | |
| AR105592A1 (es) | b-AMINOÁCIDOS b-SUSTITUIDOS Y ANÁLOGOS COMO AGENTES QUIMIOTERAPÉUTICOS Y USOS DE LOS MISMOS | |
| MX2011010295A (es) | Reactivos de radiomarcado y metodos. | |
| UY30595A1 (es) | Métodos de marcacion con fluor radioactivo | |
| BR112013013285A2 (pt) | agente de formação de imagem, precursor, métodos de preparação do agente de formação de imagem, e de formação de imagem, composição radiofarmacêutica, kit para a preparação da composição radiofarmacêutica, e, uso do agente de formação de imagem | |
| BR112012021579A2 (pt) | traçador de tomografia por emissão de pósitron, composto precursor, método para preparar o composto precursor, cassete, composição radiofarmacêutica, método de formação de imagem por tomografia por emissão de pósitron, e, método para diagnose de uma condição. | |
| EA201891444A1 (ru) | ЛИГАНДЫ mGluR2/3 ДЛЯ PET, МЕЧЕННЫЕ РАДИОАКТИВНЫМИ ИЗОТОПАМИ | |
| WO2009134405A3 (en) | Substrate based pet imaging agents | |
| WO2016040458A3 (en) | Pet probes of radiofluorinated carboximidamides for ido-targeted imaging | |
| WO2012149552A3 (en) | Dual-isotope positron emitting tomography for disease evaluation | |
| AU2010332841A8 (en) | Prostate specific membrane antigen inhibitors | |
| WO2009018175A3 (en) | Cyclic azapeptides as integrin markers | |
| UY30596A1 (es) | Marcacion con fluor radioactivo | |
| WO2009025914A3 (en) | Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging | |
| BR112012027316A2 (pt) | métodos para obter um traçador de tomografia por emissão de pósitron e para a preparação do composto, e, cassete | |
| BR112013006519A2 (pt) | composto, composição farmacêutica, métodos de fabricar um composto, de formar imagem e de detectar tecido neoplástico in vivo, e, cassete | |
| ECSP099505A (es) | Marcación radioactiva por fluoración de aziridinas | |
| BR112013006498A2 (pt) | composto | |
| WO2011084585A3 (en) | Dihydroethidine analogues and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |